EdibleKnife
Member
RISUG is the male contraceptive people have been talking about for a while and it's finally at the end of its development. Just as a reminder the procedure involves a local anesthetic before injecting a polymer gel into the vas defrens that will rupture the sperm cell membranes when passing through during ejaculation. The procedure is reversible, long lasting (effective for at least 10 years), cheap and requires a procedure that takes less than an hour.
Despite striding towards it's release, the product's inventor Sujoy Guha is having difficulty finding companies willing to distribute it.
All hope is not lost though for getting Vasagel out in the wild:
And already it's getting some commercial/pamphlet fodder:
Bloomberg - A New Kind of Male Birth Control is Coming
No point in asking Gaffers if they'd be wiling to go through the procedure since just mentioning the topic is bound to garner posts about a fear of needles. Personally, I'm completely excited at the prospect of this and wouldn't mind going through the procedure. The procedure checks all the right boxes in regards to efficacy, financial burden and time commitment. It also would be nice if women didn't solely bare the burden of keeping up with birth control pills just for the sake of enjoying condom-less sex with their partners.
Despite striding towards it's release, the product's inventor Sujoy Guha is having difficulty finding companies willing to distribute it.
Bloomberg said:A new birth control method for men has the potential to win as much as half the $10 billion market for female contraceptives worldwide and cut into the $3.2 billion of annual condom sales, businesses dominated by pharmaceutical giants Bayer AG, Pfizer Inc. and Merck & Co., according to estimates from the last major drug company to explore the area. Indias reversible procedure could cost as little as $10 in poor countries, and may provide males with years-long fertility control, overcoming compliance problems and avoiding ongoing costs associated with condoms and the female birth-control pill, which is usually taken daily.
It could also ease the burden on the 225 million women in developing countries, who the World Health Organization says have an unmet need for contraception. Yet, so far only a U.S. non-profit has taken up development of the technology abroad.
...
For Sujoy Guha, the 76-year-old biomedical engineer who invented the product, the challenge is to now find a company who wants to sell iteven though male contraception is an area Big Pharma has so far shown little interest in.
The fact that the big companies are run by white, middle-aged males who have the same feelingthat they would never do itplays a major role, said Herjan Coelingh Bennink, a gynecology professor who helped develop the contraceptives Implanon and Cerazette as head of research and development in womens health for Organon International from 1987 to 2000. If those companies were run by women, it would be totally different.
Guhas technique for impairing male fertility relies on a polymer gel thats injected into the sperm-carrying tubes in the scrotum. The gel, which has the consistency of melted chocolate, carries a positive charge that acts as a buffer on negatively charged sperm, damaging their heads and tails, and rendering them infertile.
The treatment, known as reversible inhibition of sperm under guidance, or RISUG, is reversed with a second shot that breaks down the gel, allowing sperm to reach the penis normally.
The expected launch of RISUG over the next two years will contribute to the Indian contraceptive market's 17 percent growth through 2021, according to a report last year from Pharmaion Consultants, based near New Delhi.
...
Efforts on a hormone-based male contraceptive continued in 2008 in a study co-funded by the Bill & Melinda Gates Foundation and UN agencies that was published in October. While the injected regimens efficacy was relatively good compared to other methods, the study was terminated early after a safety review. The authors noted a relatively high frequency of mild to moderate mood disorders, sparking a media uproar over perceived double standards in the development of contraceptives because the side effects seemed similar to those women experience on the pill.
Bayer, which bought Schering in 2006, stopped all research and development activities around male fertility control about a decade ago, said Astrid Kranz, a company spokeswoman.
Although an earlier clinical trial involving the administration of hormones via injection and an implant was efficient, with a tolerable side effect profile, Kranz said, the Leverkusen, Germany-based drugmaker wasnt convinced this inconvenient regimen would find sufficient market acceptance.
Male contraception isnt an area of active research for Pfizer and Merck either, representatives said. Both companies sell products for female fertility control.
Side effects aside, it would take about $100 million and 10 years to bring a hormone-based male birth control pill to marketa low-priority undertaking for pharmaceutical executives, Coelingh Bennink said.
All hope is not lost though for getting Vasagel out in the wild:
Bloomberg said:In the face of disinterest from the pharmaceutical industry, Guha licensed the technology to the Parsemus Foundation, a U.S.-based non-profit, to help establish a market for it outside India, he said.
Parsemus is working on its own version, called Vasalgel, that it plans to manufacture and distribute at near costor potentially $10 to $20 per person in low- and middle-income countriesand $400 to $600 per person in wealthier markets, Elaine Lissner, the foundations founder, said in an email.
...
Guha meantime has registered a startup in India called IcubedG Ideas Pvt. Ltd. through which he is pushing ahead with introducing the technology in his home country. He leased space in a New Delhi industrial zone in January after developing a method of mass production using a government grant. Three couples who participated in the clinical trials gathered in his Kharagpur office in February to attest to the need.
And already it's getting some commercial/pamphlet fodder:
Bloomberg said:Kinkar Ari, a 39-year-old day laborer from a nearby village, said that when he and his wife Aloka decided they didnt want more children they had a choice between tubal ligation for her or vasectomy for him, but neither could afford the time off to recuperate from the surgery.
When a public health worker told the couple about Guhas promising alternative, Ari decided to enroll in the study. The injection took 15 minutes with some local anesthesia, and after half an hour of observation at the clinic, he said he was able to walk the 2.5 kilometers home. Two days later, he was back at work. Ari was so enthused by the procedure, he convinced two other couples to have it done, he said.
Stories like that encourage Guha to persist with the project, he said, even though patents on his invention have long since expired and he wont see any personal financial gain even if it takes off worldwide.
Why should the burden be borne by the female only? he said in his office after the three couples had left. There has to be an equal partnership.
Bloomberg - A New Kind of Male Birth Control is Coming
No point in asking Gaffers if they'd be wiling to go through the procedure since just mentioning the topic is bound to garner posts about a fear of needles. Personally, I'm completely excited at the prospect of this and wouldn't mind going through the procedure. The procedure checks all the right boxes in regards to efficacy, financial burden and time commitment. It also would be nice if women didn't solely bare the burden of keeping up with birth control pills just for the sake of enjoying condom-less sex with their partners.